Skip to main content

Want a detailed portfolio tracker?

Ocugen (OCGN) P/E (2014 - 2026)

Ocugen (OCGN) P/E from Dec 31, 2014 to Jul 20, 2026. The TTM Ocugen (OCGN) P/E is -5.83. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ocugen (OCGN)

YearP/EChange
2026-5.83-3.27%
2025-6.03+48.30%
2024-4.07+137.39%
2023-1.71-54.16%
2022-3.74-75.74%
2021-15.40+57.25%
2020-9.80-166.00%
201914.84-242.89%
2018-10.39-96.31%
2017-281.48+579.26%
2016-41.44-52.32%
2015-86.91-100.95%
20149.15KN/A

Comparison Ocugen (OCGN) P/E with competitors

Ocugen (OCGN) P/E is -5.83.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.07%
ENLVEnlivex Ltd0.07-101.28%
FGENFibroGen Inc0.24-104.12%
CHRSCoherus Biosciences Inc0.85-114.55%
FBIOFortress Biotech Inc0.95-116.27%
ORMPOramed Pharmaceuticals Inc1.50-125.77%
AGENAgenus Inc3.01-151.60%
INVAInnoviva Inc3.15-154.07%
VXRTVaxart Inc3.55-160.86%
CRMDCorMedix Inc3.63-162.21%
CVACCureVac N.V.4.45-176.22%
GLPGGalapagos NV4.86-183.30%
SRPTSarepta Therapeutics Inc4.88-183.70%
ABEOAbeona Therapeutics Inc5.39-192.37%
ABUSArbutus Biopharma Corp5.60-195.93%
ZVRAZevra Therapeutics Inc5.89-200.93%
SPROSpero Therapeutics Inc6.23-206.78%
CGENCompugen Ltd6.31-208.25%
RIGLRigel Pharmaceuticals6.87-217.82%
SLXNSilexion Therapeutics Corp7.30-225.09%
OMEROmeros Corporation9.26-258.74%
AUPHAurinia Pharmaceuticals Inc9.58-264.33%
PLXProtalix BioTherapeutics Inc10.89-286.72%
ACADAcadia Pharmaceuticals Inc11.73-301.08%
TBPHTheravance Biopharma Inc12.26-310.23%
ADMAAdma Biologics Inc12.42-312.90%
HRMYHarmony Biosciences Holdings Inc13.82-336.94%
SABSSAB Biotherapeutics Inc14.14-342.36%
NAGENiagen Bioscience Inc14.82-354.05%
INCYIncyte Corp15.82-371.27%
REGNRegeneron Pharmaceuticals Inc15.86-371.85%
PBYIPuma Biotechnology Inc17.32-396.87%
CPRXCatalyst Pharmaceuticals Inc17.44-398.99%
EXELExelixis Inc17.54-400.68%
TGTXTG Therapeutics Inc18.97-425.16%
MDXGMimedx Group Inc20.55-452.36%
XOMAXOMA Royalty Corp22.87-492.18%
ARGXArgen X SE24.30-516.59%
CTMXCytomX Therapeutics Inc24.82-525.56%
XOMAOXOMA Royalty Corp25.34-534.53%
HALOHalozyme Therapeutics Inc25.62-539.32%
XOMAPXOMA Royalty Corp25.67-540.11%
VRTXVertex Pharmaceuticals Inc27.99-579.97%
RPRXRoyalty Pharma plc - Class A28.69-591.85%
SLNOSoleno Therapeutics Inc29.02-597.47%
ASNDAscendis Pharma A/S30.09-615.81%
LGNDLigand Pharmaceuticals Inc - Class B37.91-750.00%
APLSApellis Pharmaceuticals Inc39.02-769.02%
BMRNBiomarin Pharmaceutical Inc42.21-823.72%
KRYSKrystal Biotech Inc45.34-877.41%
ONCBeiGene Ltd69.54-1292.27%
PHARPharming Group N.V.75.03-1386.31%
TECHBio-Techne Corp101.96-1848.07%
VCELVericel Corp109.92-1984.59%
ALNYAlnylam Pharmaceuticals Inc117.96-2122.50%
GMABGenmab140.29-2505.27%
TLXTelix Pharmaceuticals Ltd162.15-2880.10%
CORTCorcept Therapeutics Inc212.86-3749.43%